Next generation sequencing reveals a novel pathogenic variant in the ATMgene
Introduction: Ataxia telangiectasia (A-T) is a uncommon autosomal recessive multisystemic illness. Sufferers with the A-T syndrome current a broad spectrum of illness phenotypes. The ATM (ataxia telangiectasia mutated) gene, the one causative gene for A-T.
Methodology: A affected person of Persian origin presenting with typical A-T was referred to our genetics middle for specialised genetic counseling and testing. Focused next-generation sequencing (NGS) was utilized. Sanger sequencing was used to substantiate the candidate variant. Modeling was carried out utilizing the SWISS-MODEL server.Outcomes: A homozygous stop-gain variant c.829G > T (p.E277*) was discovered within the ATM gene. This variant was confirmed by Sanger sequencing and modeling of native construction and truncated construction was carried out.
Conclusion: Thus far, only a few pathogenic variants of the ATM gene have been reported from the Iranian inhabitants. The discovering has implications in molecular diagnostic for A-T in Iran.
RIPA Lysis Buffer (Strong) |
|||
HY-K1001 | MedChemExpress | 100 mL | EUR 176.4 |
Carbol Fuchsin (ZN,Strong) |
|||
S005-125ML | EWC Diagnostics | 1 unit | EUR 3.16 |
Description: Carbol Fuchsin (ZN,Strong) |
Carbol Fuchsin (ZN,Strong) |
|||
S005-500ML | EWC Diagnostics | 1 unit | EUR 10.92 |
Description: Carbol Fuchsin (ZN,Strong) |
RIPA Lysis Buffer (Strong) |
|||
abx090624-100l | Abbexa | 100 µl | EUR 150 |
RIPA Lysis Buffer (Strong) |
|||
abx090624-1ml | Abbexa | 1 ml | Ask for price |
RIPA Lysis Buffer (Strong) |
|||
abx090624-200l | Abbexa | 200 µl | Ask for price |
Strong RIPA Lysis Buffer |
|||
EZPS03-1 | Shanghai WSHT Biotechnology | 100mL | EUR 15 |
RIPA Lysis Buffer (Strong) |
|||
E-BC-R327-100mL | Elabscience Biotech | 100mL | EUR 80 |
RIPA Lysis Buffer (Strong) |
|||
E-BC-R327-20mL | Elabscience Biotech | 20mL | EUR 25 |
RIPA Lysis Buffer (Strong) |
|||
E-BC-R327-50mL | Elabscience Biotech | 50mL | EUR 60 |
RIPA Lysis Buffer (Strong) |
|||
E-BC-R327-each | Elabscience Biotech | each | Ask for price |
WB Stripping Solution Strong |
|||
05677-65 | NACALAI TESQUE | 500ML | EUR 142.8 |
Arg-SEC Mobile Phase(Strong) |
|||
17000-51 | NACALAI TESQUE | 1L | EUR 105 |
Pierce Seal Strong Roll - 1ROLL |
|||
PCR0636 | Scientific Laboratory Supplies | 1ROLL | EUR 1314.9 |
HiDecal (Strong decalcifying solution) |
|||
R085-500ML | EWC Diagnostics | 1 unit | EUR 21.95 |
Description: HiDecal (Strong decalcifying solution) |
Pierce Seal Strong Sheets - PK100 |
|||
PCR0632 | Scientific Laboratory Supplies | PK100 | EUR 140.4 |
replacement tip Kit strong thick |
|||
INS2090 | Scientific Laboratory Supplies | EACH | EUR 8.33 |
Modified Duncan Strong (DS) Medium |
|||
M1237-500G | EWC Diagnostics | 1 unit | EUR 80.55 |
Description: Modified Duncan Strong (DS) Medium |
Pierce Seal Strong Roll610mX78mm - 1ROLL |
|||
PCR0628 | Scientific Laboratory Supplies | 1ROLL | EUR 1104.3 |
Western Stripping buffer (Strong alkaline) |
|||
EZWB03-1-100mL | Shanghai WSHT Biotechnology | 100mL | EUR 9.6 |
Western Stripping buffer (Strong alkaline) |
|||
EZWB03-1-500mL | Shanghai WSHT Biotechnology | 500mL | EUR 28.8 |
Tweezers Fine Strong CF Tips - EACH |
|||
INS5058 | Scientific Laboratory Supplies | EACH | EUR 37.6 |
Tweezers Flat Strong CF Tips - EACH |
|||
INS5100 | Scientific Laboratory Supplies | EACH | EUR 43.92 |
PCR Foil Seal Strong Sheets - PK100 |
|||
PCR0528 | Scientific Laboratory Supplies | PK100 | EUR 211.95 |
EP Reagent Sodium Hypochlorite Sol. Strong - 500ML |
|||
10816005 | Scientific Laboratory Supplies | 500ML | EUR 136.35 |
Pierce Seal Strong Sample Roll - 1ROLL |
|||
PCR0630 | Scientific Laboratory Supplies | 1ROLL | EUR 59.63 |
replacement tip Kit strong thick - EACH |
|||
INS2058 | Scientific Laboratory Supplies | EACH | EUR 11.65 |
replacement tip Kit strong point - EACH |
|||
INS2094 | Scientific Laboratory Supplies | EACH | EUR 11.65 |
Modified Duncan Strong (DS) HiVeg Medium |
|||
MV1237-500G | EWC Diagnostics | 1 unit | EUR 80.55 |
Description: Modified Duncan Strong (DS) HiVeg Medium |
Strong RIPA Lysis Buffer (without inhibitors) |
|||
EZPS03-2 | Shanghai WSHT Biotechnology | 100mL | EUR 12.6 |
EP Reagent Sodium Hydroxide Sol. Strong - 1L |
|||
1081404 | Scientific Laboratory Supplies | 1L | EUR 191.7 |
Tweezers, Rubis Sturdy, Strong Pointed, 115mm, 4.5€ |
|||
25046-1 | Polysciences Europe GmbH | 1EA | EUR 48 |
Silver Protein for Histology, Strong (not certified) |
|||
25108-25 | Polysciences Europe GmbH | 25g | EUR 431 |
Description: 9015-51-4 |
Silver Protein for Histology, Strong (not certified) |
|||
25108-5 | Polysciences Europe GmbH | 5g | EUR 113 |
Description: 9015-51-4 |
Magnetic Base Support Z w/ Strong Magnet - 34.5mm |
|||
M-R-1013161 | MiTeGen | 1 UNIT | EUR 46 |
Description: Magnetic Base Support Z w/ Strong Magnet - 34.5mm |
Magnetic Base Support Z w/ Strong Magnet - 27.5mm |
|||
M-R-1015229 | MiTeGen | 1 UNIT | EUR 46 |
Description: Magnetic Base Support Z w/ Strong Magnet - 27.5mm |
UCW5072, Low TOC Strong Base Anion Resin, OH Form |
|||
50240-1 | Polysciences Europe GmbH | 1000ml | EUR 192 |
UCW5072, Low TOC Strong Base Anion Resin, OH Form |
|||
50240-250 | Polysciences Europe GmbH | 250ml | EUR 62 |
Genistin |
|||
1535-10 | Biovision | each | EUR 196.8 |
Genistin |
|||
G350020 | Toronto Research Chemicals | 10mg | EUR 63 |
Description: 529-59-9 |
Genistin |
|||
GC2802-10 | Glentham Life Sciences | 10 | EUR 242.4 |
Genistin |
|||
GC2802-100 | Glentham Life Sciences | 100 | EUR 960.1 |
Genistin |
|||
GC2802-25 | Glentham Life Sciences | 25 | EUR 382.3 |
Genistin |
|||
GC2802-250 | Glentham Life Sciences | 250 | EUR 1845.7 |
Genistin |
|||
GC2802-50 | Glentham Life Sciences | 50 | EUR 577.8 |
Genistin |
|||
540154 | MedKoo Biosciences | 500.0mg | EUR 450 |
Genistin |
|||
T2882-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Genistin |
Genistin |
|||
T2882-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Genistin |
Genistin |
|||
T2882-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Genistin |
Genistin |
|||
T2882-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Genistin |
Genistin |
|||
T2882-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Genistin |
Genistin |
|||
TB0370-1000 | ChemNorm | 4X20mg | EUR 321.6 |
Genistin |
|||
HY-N0595 | MedChemExpress | 50mg | EUR 170.4 |
Genistin |
|||
N1860-20 | ApexBio | 20 mg | EUR 100 |
Description: TdT inhibitor |
Genistin |
|||
abx282781-100g | Abbexa | 100 µg | Ask for price |
Genistin |
|||
abx282781-20g | Abbexa | 20 µg | EUR 106.25 |
Genistin |
|||
abx282781-50g | Abbexa | 50 µg | EUR 250 |
A510, Type 2 Macroporous Strong Base Rsin, Chloride Form |
|||
50223-1 | Polysciences Europe GmbH | 1000ml | EUR 144 |
Description: 69011-15-0 |
DiagAg™ Strong Anion Exchange Agarose Particles, 40 μm |
|||
DAG-CL23-08 | Creative Diagnostics | 25 mL | EUR 1150 |
A510, Type 2 Macroporous Strong Base Resin, Chloride Form |
|||
50223-250 | Polysciences Europe GmbH | 250ml | EUR 47 |
Description: 69011-15-0 |
A400, Type 1 Porous Strong Base Anion Resin, Chorlide Form |
|||
50218-1 | Polysciences Europe GmbH | 1000ml | EUR 144 |
Description: 9052-45-3 |
A400, Type 1 Porous Strong Base Anion Resin, Chorlide Form |
|||
50218-250 | Polysciences Europe GmbH | 250ml | EUR 47 |
Description: 9052-45-3 |
Genistin, >99% |
|||
BC034-025 | GenDepot | 25mg | EUR 278.4 |
Genistin, >99% |
|||
BC034-050 | GenDepot | 50mg | EUR 327.6 |
Genistin, >99% |
|||
BC034-100 | GenDepot | 100mg | EUR 537.6 |
Genistin(Genistoside) |
|||
E1KS2301 | EnoGene | 25mg | EUR 211.2 |
Genistin malonate |
|||
TB0588-0005 | ChemNorm | 10mg | EUR 886.8 |
Optically clear sealing film for qPCR, Strong Bond, for PP plates, 100/pk |
|||
MS1000-PCR2 | Benchmark Scientific | 1 each | EUR 149.35 |
DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 24-45 µm |
|||
DAG-YS23-27 | Creative Diagnostics | 25 mL | EUR 850 |
Genistin 6''-O-Acetate |
|||
G350030 | Toronto Research Chemicals | 100mg | EUR 7600 |
Description: 73566-30-0 |
Genistin 6''-O-Malonate |
|||
G350035 | Toronto Research Chemicals | 250mg | EUR 11200 |
Description: 51011-05-3 |
Foil seals, strong bonding for cold storage (-200 to 110°C) and DMSO, for PP plates, 100/pk |
|||
MS1000-F2 | Benchmark Scientific | 1 each | EUR 149.35 |
DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 45-165 µm, Low Capacity |
|||
DAG-YS23-28 | Creative Diagnostics | 25 mL | EUR 850 |
DiagAg™ Phenyl Agarose Strong Hydrophobic Medium, 6% Crosslinked, 45-165 µm, High Capacity |
|||
DAG-YS23-29 | Creative Diagnostics | 25 mL | EUR 850 |
Estrogen receptor (ER) IHC control with strong, moderate, low/negative expressersHumanBreastBreastIHC control |
|||
ERC083 | Pantomics | 1.5mm | EUR 50 |
Rat Strongyloid IgG |
|||
QY-E11978 | Qayee Biotechnology | 96T | EUR 420 |
genesig Easy kit for Strongylus vulgaris |
|||
Z-Path-S.vulgaris-EASY | Novacyt Group | 50 tests | EUR 410 |
Description: S.vulgaris |
Strongyloides IgG/IgM |
|||
DESTRO0690 | Demeditec Diagnostics | 96 | EUR 134 |
Strongzyme Goat anti Mouse IgG (H+L) (HRP) |
|||
43R-1653 | Fitzgerald | 1 ml | EUR 763.2 |
Description: Strongzyme Goat anti-Mouse IgG (H+L) secondary antibody (HRP) |
Strongzyme Rabbit anti Goat IgG (H+L) (HRP) |
|||
43R-1650 | Fitzgerald | 1 ml | EUR 813 |
Description: Strongzyme Rabbit anti Goat IgG (H + L) (HRP) secondary antibody |
Strongzyme Goat anti Rabbit IgG (H + L) (HRP) |
|||
43R-1652 | Fitzgerald | 1 ml | EUR 648 |
Description: Strongzyme Goat anti Rabbit IgG (H + L) secondary antibody (HRP) |
QPCR Kit DNA Strongylus vulgaris |
|||
MOL8942 | Scientific Laboratory Supplies | EACH | EUR 987.17 |
Human Strongyloides IgG Elisa Kit |
|||
EK713927 | AFG Bioscience LLC | 96 Wells | EUR 0.4 |
QPCR Kit DNA Strongylus vulgaris - EACH |
|||
MOL8940 | Scientific Laboratory Supplies | EACH | EUR 1129.51 |
genesig Real-time PCR detection kit for Strongylus vulgaris |
|||
Z-Path-S-vulgaris | Novacyt Group | 150 tests | EUR 808 |
Description: S.vulgaris |
genesig Std Real-time PCR detection kit, Strongylus vulgaris |
|||
Z-Path-S-vulgaris-std | Novacyt Group | 150 tests | EUR 602 |
Description: S.vulgaris |
Strongyloides (IgG/IgM) ELISA Kit (Human) (OKNA00174) |
|||
OKNA00174 | Aviva Systems Biology | 96 Wells | EUR 505.2 |
Description: Description of target: Strongyloides is a genus containing some 50 species of obligate gastrointestinal parasites of vertebrates. Strongyloides stercoralis is the scientific name of a human parasitic roundworm causing the disease of strongyloidiasis. Its common name is pinworm in the UK and threadworm in the US. The Strongyloides stercoralis nematode can parasitize humans. The adult parasitic stage lives in tunnels in the mucosa of the small intestine.S. stercoralis can be found in areas with tropical and subtropical climates but cases also occur in temperate area, more frequently in rural areas. S. stercoralis has a very low prevalence in societies where fecal contamination of soil or water is rare. Many people infected are usually asymptomatic at first. Symptoms include dermatitis: swelling, itching, larva currens, and mild hemorrhage at the site where the skin has been penetrated. If the parasite reaches the lungs, the chest may feel as if it is burning, and wheezing and coughing may result, along with pneumonia-like symptoms (Löffler's syndrome). The intestines could eventually be invaded, leading to burning pain, tissue damage, sepsis, and ulcers. In severe cases, edema may result in obstruction of the intestinal tract, as well as loss of peristaltic contractions. Strongyloides infection in immunocompromised individuals (particularly following the administration of steroids, for example following transplant surgery) can result in disseminated strongyloidiasis, in which worms move beyond the confines of the gut into other organs. This is fatal unless antiStrongyloides therapy is given.Locating juvenile larvae, either rhabditiform or filariform, in recent stool samples will confirm the presence of this parasite. Other techniques used include direct fecal smears, culturing fecal samples on agar plates, serodiagnosis through ELISA, and duodenal fumigation.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Reverse Capture Sandwich ELISA ;Sensitivity: Sensitivity is determined as the probability of the assay indicating a positive score in samples with the specific analyte present: 87.9% |
StrongZyme Streptavidin-PolyHRP (High Load) |
|||
43R-1645 | Fitzgerald | 1 mg | EUR 380 |
Description: StrongZyme Streptavidin-PolyHRP conjugate (High Load) |
Fscn1 (GFP-tagged) - Mouse fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) (Fscn1) |
|||
MG207918 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn1 (untagged) - Mouse fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) (Fscn1), (10ug) |
|||
MC216780 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN1 (GFP-tagged) - Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1) |
|||
RG203031 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN1 (untagged)-Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1) |
|||
SC118222 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn1 (Myc-DDK-tagged) - Mouse fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) (Fscn1) |
|||
MR207918 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN1 (untagged)-Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1) |
|||
SC320744 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn2 (untagged) - Mouse fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2), (10ug) |
|||
MC216896 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn3 (untagged ORF) - Rat fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3), (10 ug) |
|||
RN201308 | Origene Technologies GmbH | 10 µg | Ask for price |
Rabbit polyclonal antibody to Fascin (fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus)) |
|||
TA308801 | Origene Technologies GmbH | 100 µl | Ask for price |
FSCN1 (Myc-DDK-tagged)-Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1) |
|||
RC203031 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1), mGFP tagged |
|||
RC203031L2 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1), mGFP tagged |
|||
RC203031L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Fscn1 (mGFP-tagged) - Mouse fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) (Fscn1) |
|||
MR207918L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn2 (untagged ORF) - Rat fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2), (10 ug) |
|||
RN206219 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn3 (GFP-tagged) - Mouse fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3) |
|||
MG207995 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn3 (untagged) - Mouse fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3), (10ug) |
|||
MC216995 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN3 (GFP-tagged) - Human fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (FSCN3) |
|||
RG207492 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn2 (Myc-DDK-tagged ORF) - Rat fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2), (10 ug) |
|||
RR206219 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn3 (Myc-DDK-tagged ORF) - Rat fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3), (10 ug) |
|||
RR201308 | Origene Technologies GmbH | 10 µg | Ask for price |
3`UTR clone of fascin homolog 1 actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1) for miRNA target validation |
|||
SC213307 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN3 (untagged)-Human fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (FSCN3) |
|||
SC323970 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1), Myc-DDK-tagged |
|||
RC203031L1 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1), Myc-DDK-tagged |
|||
RC203031L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn2 (Myc-DDK-tagged) - Mouse fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2) |
|||
MR225952 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Fscn1 (Myc-DDK-tagged) - Mouse fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) (Fscn1) |
|||
MR207918L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Fscn2 (GFP-tagged) - Mouse fascin homolog 2 actin-bundling protein retinal (Strongylocentrotus purpuratus) (Fscn2), (10ug) |
|||
MG225952 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN3 (Myc-DDK-tagged)-Human fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (FSCN3) |
|||
RC207492 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (FSCN3), mGFP tagged |
|||
RC207492L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Fscn2 (Myc-DDK-tagged ORF) - Rat fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2), (1 |
|||
RR206219L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Fscn2 (mGFP-tagged ORF) - Rat fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2), (10 u |
|||
RR206219L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, FSCN1 (Myc-DDK tagged) - Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1), 200ul, >10^ |
|||
RC203031L1V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, FSCN1 (mGFP-tagged) - Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1), 200ul, >10^7 T |
|||
RC203031L2V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, FSCN1 (Myc-DDK tagged) - Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1), 200ul, >10^ |
|||
RC203031L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, FSCN1 (mGFP-tagged) - Human fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) (FSCN1), 200ul, >10^7 T |
|||
RC203031L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF clone of Fscn2 (mGFP-tagged) - Mouse fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2) |
|||
MR225952L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Fscn1 (Myc-DDK-tagged) - Mouse fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) (Fscn1), 200ul, >10^ |
|||
MR207918L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Fscn1 (GFP-tagged) - Mouse fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) (Fscn1), 200ul, >10^7 TU |
|||
MR207918L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Fscn3 (Myc-DDK-tagged) - Mouse fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3) |
|||
MR207995 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, FSCN2 (Myc-DDK tagged) - Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), tr |
|||
RC221223L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF clone of Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 1, mGFP ta |
|||
RC221223L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, FSCN2 (Myc-DDK tagged) - Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), tr |
|||
RC221276L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF clone of Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 2, mGFP ta |
|||
RC221276L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (FSCN3), Myc-DDK-tagged |
|||
RC207492L3 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN2 (GFP-tagged) - Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 1 |
|||
RG221223 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN2 (GFP-tagged) - Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 2 |
|||
RG221276 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Fscn2 (Myc-DDK-tagged ORF) - Rat fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2), |
|||
RR206219L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Fscn2 (GFP-tagged ORF) - Rat fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2), 200u |
|||
RR206219L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF clone of Fscn3 (Myc-DDK-tagged ORF) - Rat fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3), |
|||
RR201308L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Fscn3 (mGFP-tagged ORF) - Rat fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3), (1 |
|||
RR201308L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Fscn3 (GFP-tagged ORF) - Rat fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3), 2 |
|||
RR201308L4V | Origene Technologies GmbH | 200 µl | Ask for price |
FSCN2 (untagged)-Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 1 |
|||
SC303980 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Fscn2 (Myc-DDK-tagged) - Mouse fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2) |
|||
MR225952L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Fscn2 (GFP-tagged) - Mouse fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2), 200ul, |
|||
MR225952L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF clone of Fscn3 (Myc-DDK-tagged) - Mouse fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3) |
|||
MR207995L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Fscn3 (mGFP-tagged) - Mouse fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3) |
|||
MR207995L4 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN2 (untagged)-Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 2 |
|||
SC315582 | Origene Technologies GmbH | 10 µg | Ask for price |
FSCN2 (Myc-DDK-tagged)-Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 1 |
|||
RC221223 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 1, Myc-DDK |
|||
RC221223L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, FSCN2 (mGFP-tagged) - Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), trans |
|||
RC221223L4V | Origene Technologies GmbH | 200 µl | Ask for price |
FSCN2 (Myc-DDK-tagged)-Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 2 |
|||
RC221276 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), transcript variant 2, Myc-DDK |
|||
RC221276L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, FSCN2 (mGFP-tagged) - Human fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (FSCN2), trans |
|||
RC221276L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, FSCN3 (Myc-DDK tagged) - Human fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (FSCN3), |
|||
RC207492L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, FSCN3 (mGFP-tagged) - Human fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (FSCN3), 20 |
|||
RC207492L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Fscn3 (Myc-DDK-tagged ORF) - Rat fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3 |
|||
RR201308L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Fscn2 (Myc-DDK-tagged) - Mouse fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) (Fscn2), 20 |
|||
MR225952L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Fscn3 (Myc-DDK-tagged) - Mouse fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3), |
|||
MR207995L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Fscn3 (GFP-tagged) - Mouse fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) (Fscn3), 200 |
|||
MR207995L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Human Strontium (Strontium) Elisa Kit |
|||
EK710512 | AFG Bioscience LLC | 96 Wells | EUR 0.98 |
Strontium Oxide |
|||
32315-42 | NACALAI TESQUE | 25G | EUR 61.6 |
Strontium Oxide |
|||
abx186564-500g | Abbexa | 500 g | EUR 309.6 |
Strontium oxide, 99.5% |
|||
GX8751-50 | Glentham Life Sciences | 50 | EUR 585.6 |
Strontium Iodate 99% |
|||
S09620 | Pfaltz & Bauer | 10G | EUR 135 |
Strontium Acetate |
|||
32302-02 | NACALAI TESQUE | 25G | EUR 22.75 |
Strontium acetate |
|||
S09490 | Pfaltz & Bauer | 100G | EUR 216.3 |
Strontium bromide 99% |
|||
S09540 | Pfaltz & Bauer | 100G | EUR 242.2 |
Strontium ferrite 99.5% |
|||
S09575 | Pfaltz & Bauer | 5G | EUR 191.06 |
Familial dilated cardiomyopathy brought on by a novel variant within the Lamin A/C gene: a case report
Background: Familial dilated cardiomyopathy (FDCM) is mostly inherited as an autosomal dominant trait. The Lamin A/C (LMNA) gene variants have been recognized to be related to DCM, conductive system problems, kind 2 Emery-Dreifuss muscular dystrophy and a number of other different problems. Right here, we reported a novel variant within the LMNA gene that is likely to be associated to FDCM.
Case presentation: A 30-year-old younger man was hospitalized for chest tightness, excessive fatigue, palpitation and impaired exercise tolerance. He had scientific traits together with cardiac dilatation, atrial tachyarrhythmia, extreme conductive system problems, and dyskinesia of each higher limbs and the neck. Genetic sequence evaluation indicated that the affected person carried a novel c.1325 T>C heterozygous LMNA gene variant. Catheter ablation and cardiac resynchronization remedy with pacing perform (CRT-P) have been carried out to deal with the arrhythmia.
Conclusion: The variant c.1325 T>C is a novel variant within the LMNA gene that has not been beforehand reported. Younger sufferers with DCM, conductive system problems and skeletal myopathy ought to be alert to the potential for LMNA gene variant. Cardiac resynchronization remedy (CRT) could also be an affordable selection for affected person carrying a LMNA gene variant with third-degree atrioventricular block even when the left ventricular ejection fraction is preserved with the intention to stop the deterioration of cardiac perform brought on by proper ventricular pacing dependency.
Genetic evaluation of kids with congenital ocular anomalies in three ecological areas of Nepal: a section II of Nepal pediatric ocular illnesses research
Background: Genetic eye illnesses represent a big and heterogeneous group of childhood ocular morbidity. Particular person illnesses could trigger a number of structural anomalies and developmental options. Nepal Pediatric Ocular Illness Research (NPODS) was a population-based epidemiological research carried out throughout three ecological areas of Nepal to find out the prevalence and etiology of childhood ocular morbidity and blindness. In Part II of this research, genetic evaluation was carried out for kids who have been discovered to have congenital ocular anomalies.
Methodology: It was a cross sectional descriptive research. A complete of 10,270 youngsters throughout three totally different ecological areas in Nepal (Low lands, hills, and mountains) underwent ocular examinations in NPODS. Out of 374 (3.6%) of kids with ocular abnormalities, 30 have been considered congenital in nature. Focused genetic evaluation, together with genotyping for genes particular to presenting phenotype, was carried out for 25 youngsters utilizing serum samples.
Outcomes: Out of 25 youngsters, 18 had significant genetic outcomes. Evaluation revealed one missense alteration G12411T of Zinc Finger Homeobox 4 (ZFHX4) gene in a single participant amongst 10 with congenital ptosis and one other missense variation T > C P. Y374 C of Signaling Receptor and Transporter Retinol 6 (STRA6) gene in a single participant amongst Three with microphthalmos.
Conclusion: The research is first of its sort from Nepal and mutant genes have been distinctive to Nepalese Inhabitants. Additional evaluation of genetic components is essential to higher perceive genetic affiliation with ocular illnesses and situations. This helps additional in genetic counseling and doubtless gene remedy to forestall blindness from these situations.
Doxorubicin Hydrochloride |
|||
40410004-1 | Glycomatrix | 10 mg | EUR 136.34 |
Doxorubicin Hydrochloride |
|||
40410004-2 | Glycomatrix | 25 mg | EUR 273.17 |
Doxorubicin Hydrochloride |
|||
D558000 | Toronto Research Chemicals | 100mg | EUR 136 |
Description: 25316-40-9 |
Doxorubicin hydrochloride |
|||
GA4969-100MG | Glentham Life Sciences | 100 mg | EUR 217.2 |
Doxorubicin hydrochloride |
|||
GA4969-10MG | Glentham Life Sciences | 10 mg | EUR 93.6 |
Doxorubicin hydrochloride |
|||
GA4969-25MG | Glentham Life Sciences | 25 mg | EUR 117.6 |
Doxorubicin hydrochloride |
|||
GA4969-50MG | Glentham Life Sciences | 50 mg | EUR 151.2 |
Doxorubicin hydrochloride |
|||
ADC-P-014 | Creative Biolabs | unit | Ask for price |
Doxorubicin Hydrochloride |
|||
20-abx076623 | Abbexa |
|
|
Doxorubicin hydrochloride |
|||
TNC00267 | ChemNorm | 20mg | Ask for price |
Doxorubicin (hydrochloride) |
|||
HY-15142 | MedChemExpress | 100mg | EUR 176.4 |
Doxorubicin Hydrochloride |
|||
SIH-390-10MG | Stressmarq | 10 mg | EUR 129 |
Description: Apoptosis Inducer |
Doxorubicin Hydrochloride |
|||
SIH-390-50MG | Stressmarq | 50 mg | EUR 465 |
Description: Apoptosis Inducer |
Doxorubicin hydrochloride |
|||
T1020-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride, 98% |
|||
GP9056-100 | Glentham Life Sciences | 100 | EUR 140.2 |
Doxorubicin hydrochloride, 98% |
|||
GP9056-25 | Glentham Life Sciences | 25 | EUR 56.1 |
Doxorubicin hydrochloride USP |
|||
D005-10MG | TOKU-E | 10 mg | EUR 117.34 |
Description: C27H29NO11•HCl |
Doxorubicin hydrochloride USP |
|||
D005-25MG | TOKU-E | 25 mg | EUR 234.67 |
Description: C27H29NO11•HCl |
10 mM Doxorubicin hydrochloride |
|||
DOX10 | ProFoldin | 100 ul | EUR 92 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-10 | Glentham Life Sciences | 10 | EUR 47.4 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-100 | Glentham Life Sciences | 100 | EUR 150.4 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-25 | Glentham Life Sciences | 25 | EUR 67.2 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-50 | Glentham Life Sciences | 50 | EUR 95 |
Doxorubicin-hydrazone-caproyl-maleimide Hydrochloride (~80%) |
|||
D399610 | Toronto Research Chemicals | 250mg | EUR 150 |
Doxorubicinol hydrochloride |
|||
T40736-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol hydrochloride |
|||
T40736-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol hydrochloride |
|||
T40736-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol hydrochloride |
|||
T40736-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol hydrochloride |
|||
T40736-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol Hydrochloride (>90%) (Mixture of diastereomers) |
|||
D558020 | Toronto Research Chemicals | 10mg | EUR 141 |
Hydroxyacetyl Doxorubicin |
|||
H415946 | Toronto Research Chemicals | 25mg | EUR 15000 |
Doxorubicin |
|||
D063-100MG | TOKU-E | 100 mg | EUR 1261.2 |
Doxorubicin |
|||
D063-25MG | TOKU-E | 25 mg | EUR 131.79 |
Description: C27H29NO11 |
Doxorubicin |
|||
D063-5MG | TOKU-E | 5 mg | EUR 460.82 |
Description: C27H29NO11 |
Doxorubicin |
|||
ADC-P-013 | Creative Biolabs | unit | Ask for price |
Doxorubicin |
|||
A3966-10 | ApexBio | 10 mg | EUR 48 |
Description: Topo II inhibitor,immunosuppresive antineoplastic antibiotic |
Doxorubicin |
|||
A3966-100 | ApexBio | 100 mg | EUR 154 |
Description: Topo II inhibitor,immunosuppresive antineoplastic antibiotic |
Doxorubicin |
|||
A3966-25 | ApexBio | 25 mg | EUR 67 |
Description: Topo II inhibitor,immunosuppresive antineoplastic antibiotic |
Doxorubicin |
|||
A3966-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 44 |
Description: Topo II inhibitor,immunosuppresive antineoplastic antibiotic |
Doxorubicin |
|||
A3966-S | ApexBio | Evaluation Sample | EUR 22 |
Description: Topo II inhibitor,immunosuppresive antineoplastic antibiotic |
Doxorubicin |
|||
abx188695-1g | Abbexa | 1 g | EUR 560.4 |
Doxorubicin |
|||
T1456-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
HY-15142A | MedChemExpress | 100mg | EUR 258 |
Doxorubicin HCl |
|||
20-abx184016 | Abbexa |
|
|
Doxorubicin HCl |
|||
abx076623-25ml | Abbexa | 25 ml | EUR 187.5 |
Doxorubicin HCl |
|||
abx076623-5ml | Abbexa | 5 ml | EUR 118.75 |
Doxorubicin [BSA] |
|||
DAG-WT1084B | Creative Diagnostics | 1 mg | EUR 520 |
Description: Synthetic |
Doxorubicin [OVA] |
|||
DAG-WT1084O | Creative Diagnostics | 1 mg | EUR 520 |
Description: Synthetic |
Doxorubicin 10mM |
|||
TG4120 | TopoGen | 0.25ml | EUR 187.2 |
Doxorubicin-SMCC |
|||
406622 | MedKoo Biosciences | 1.0mg | EUR 90 |
Doxorubicin-MVCP |
|||
T31567-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-SMCC |
|||
T15161-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin HCl, 100mg |
|||
R2531 | ACTGene | 100mg | EUR 1080.79 |
Doxorubicin HCl, 100mg |
|||
R2531-100mg | ACTGene | each | EUR 1560 |
Doxorubicin HCl, 10mg |
|||
R2531-10mg | ACTGene | each | EUR 236.4 |
Adriamycin (Doxorubicin) |
|||
E1KS1208 | EnoGene | 10mg | EUR 276 |
Doxorubicin Free Base |
|||
100960 | MedKoo Biosciences | 10.0mg | EUR 150 |
Doxorubicin (Adriamycin) HCl |
|||
A1832-10 | ApexBio | 10 mg | EUR 36 |
Description: Antitumour antibiotic,inhibits TOPO II. |
Doxorubicin (Adriamycin) HCl |
|||
A1832-100 | ApexBio | 100 mg | EUR 128 |
Description: Antitumour antibiotic,inhibits TOPO II. |
Doxorubicin (Adriamycin) HCl |
|||
A1832-25 | ApexBio | 25 mg | EUR 52 |
Description: Antitumour antibiotic,inhibits TOPO II. |
Doxorubicin (Adriamycin) HCl |
|||
A1832-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 44 |
Description: Antitumour antibiotic,inhibits TOPO II. |
4'O-Benzyl Doxorubicin |
|||
B788120 | Toronto Research Chemicals | 100mg | EUR 1200 |
Description: 677017-23-1 |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-1g | TargetMol Chemicals | 1g | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
7-Deoxy Doxorubicin Aglycone (> 75%) |
|||
D232910 | Toronto Research Chemicals | 10mg | EUR 299 |
Description: 38554-25-5 |
PEGylated Liposomal Doxorubicin- 2 mg |
|||
PHPC002DX | ProFoldin | 2 mg | EUR 140.62 |
Description: This product includes 1 ml of liposomal doxorubicin at concentrations of 2 mg/ml doxorubicin and 16 mg/ml of lipids. |
PEGylated Liposomal Doxorubicin- 20 mg |
|||
PHPC020DX | ProFoldin | 20 mg | EUR 358.62 |
Description: This product includes 10 ml of liposomal doxorubicin at concentrations of 2 mg/ml doxorubicin and 16 mg/ml of lipids. |
Doxorubicin-hydrazone-caproyl-maleimide |
|||
D558040 | Toronto Research Chemicals | 100mg | EUR 1800 |
Description: 151038-96-9 |
Human Doxorubicin-Stimulated HeLa Whole Cell Lysate |
|||
IHUHELADTLW500UG | Innovative research | each | EUR 327 |
Description: Human Doxorubicin-Stimulated HeLa Whole Cell Lysate |
Human Doxorubicin-Stimulated HeLa Nuclear Extract Lysate |
|||
IHUHELADTLN200UG | Innovative research | each | EUR 427 |
Description: Human Doxorubicin-Stimulated HeLa Nuclear Extract Lysate |
7,8-Desacetyl-9,10-dehydro Daunorubicinone (~90%)(Doxorubicin Impurity) |
|||
D288680 | Toronto Research Chemicals | 10mg | EUR 4281 |
Description: 1159977-24-8 |
Human HeLa (Cervix Adenocarcinoma) Whole Cell Lysate - Doxorubicin Stimulated |
|||
HCL-2010 | Alpha Diagnostics | 100ug | EUR 255.6 |
6,8,11-Trihydroxy-1-methoxy-5,12-naphthacenedione (Doxorubicin Impurity) |
|||
T795210 | Toronto Research Chemicals | 10mg | EUR 244 |
Description: 64845-67-6 |
Human HeLa (Cervix Adenocarcinoma) Cell Nuclear Extract - Doxorubicin Stimulated |
|||
HCL-2004 | Alpha Diagnostics | 100ug | EUR 270 |
Des-[(4-Amino-2,3,6-trideoxy-hexapyranosyl)oxy)-1-methyl] 2-Carboxylate Doxorubicin |
|||
D558001 | Toronto Research Chemicals | 100mg | EUR 4500 |
Doxorubicin.HCl |
|||
1527-5 | Biovision | each | EUR 183.6 |
Doxorubicinol (>90%) |
|||
D558025 | Toronto Research Chemicals | 2.5mg | EUR 1929 |
Doxorubicinol |
|||
T25349-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicinol |
Doxorubicinol |
|||
T25349-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicinol |
Doxorubicinol |
|||
T25349-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicinol |
Doxorubicinol |
|||
T25349-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicinol |
Doxorubicinol |
|||
T25349-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicinol |
Doxorubicinone |
|||
D559070 | Toronto Research Chemicals | 25mg | EUR 244 |
Description: 24385-10-2 |
Doxorubicinone |
|||
T29673-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicinone |
Doxorubicinone |
|||
T29673-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicinone |
Doxorubicinone |
|||
T29673-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicinone |
Doxorubicinone |
|||
T29673-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicinone |
Doxorubicinone |
|||
T29673-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicinone |
APY29 Hydrochloride Salt |
|||
A735422 | Toronto Research Chemicals | 100mg | EUR 224 |
Axomadol Hydrochloride Salt |
|||
A583490 | Toronto Research Chemicals | 100mg | EUR 11200 |
Description: 187219-95-0 |
Morphine Hydrochloride Salt |
|||
M652280 | Toronto Research Chemicals | 100mg | EUR 500 |
Description: 52-26-6 |
OPC 4392 Hydrochloride Salt |
|||
O667500 | Toronto Research Chemicals | 100mg | EUR 193 |
3-N-Carboxylic Acid 1-beta-D-Glucuronide-[4-(methyl)phenyl]carbamate Ester Doxorubicin |
|||
C177855 | Toronto Research Chemicals | 50mg | EUR 11200 |
Description: 211364-63-5 |
Erlotinib, Hydrochloride Salt |
|||
1588-100 | Biovision | each | EUR 202.8 |
Erlotinib, Hydrochloride Salt |
|||
1588-1000 | Biovision | each | EUR 477.6 |
Carazolol Hydrochloride Salt |
|||
C175810 | Toronto Research Chemicals | 100mg | EUR 138 |
Description: 51997-43-4 |
Carazolol hydrochloride salt |
|||
574509 | MedKoo Biosciences | 50.0mg | EUR 285 |
Tofenacin Hydrochloride Salt |
|||
T528500 | Toronto Research Chemicals | 10mg | EUR 339 |
Osutidine Hydrochloride Salt |
|||
O703910 | Toronto Research Chemicals | 100mg | EUR 1696 |
CHIR 99021 Hydrochloride Salt |
|||
C292157 | Toronto Research Chemicals | 100mg | EUR 178 |
Difloxacin Hydrochloride Salt |
|||
D445600 | Toronto Research Chemicals | 100mg | EUR 460 |
Description: 91296-86-5 |
Dimethacrine Hydrochloride Salt |
|||
D460270 | Toronto Research Chemicals | 100mg | EUR 4500 |
Description: 100000-17-7 |
Ramifenazone Hydrochloride Salt |
|||
R110500 | Toronto Research Chemicals | 100mg | EUR 86 |
Description: 18342-39-7 |
Pexidartinib Hydrochloride Salt |
|||
P293640 | Toronto Research Chemicals | 100mg | EUR 800 |
Description: 2040295-03-0 |
Volinanserin Hydrochloride Salt |
|||
V755000 | Toronto Research Chemicals | 1mg | EUR 598 |
Lysinoalanine Hydrochloride Salt |
|||
L488650 | Toronto Research Chemicals | 10mg | EUR 219 |
Description: 93113-28-1 |
Aposcopolamine Hydrochloride Salt |
|||
A729005 | Toronto Research Chemicals | 100mg | EUR 230 |
Description: 890416-03-2 |
7,8,9,10-Dehydro Doxorubicinone (~70%) |
|||
D229580 | Toronto Research Chemicals | 10mg | EUR 5528 |
Description: 1159977-23-7 |
I-CBP 112 Hydrochloride Salt |
|||
I163880 | Toronto Research Chemicals | 5mg | EUR 403 |
Description: 2147701-33-3 |
Bleomycin A5 Hydrochloride Salt |
|||
B595750 | Toronto Research Chemicals | 10mg | EUR 230 |
Description: 55658-47-4 |
Erlotinib, Hydrochloride Salt, >99% |
|||
BC026-101 | GenDepot | 1g | EUR 327.6 |
Erlotinib, Hydrochloride Salt, >99% |
|||
BC026-102 | GenDepot | 2g | EUR 465.6 |
Erlotinib, Hydrochloride Salt, >99% |
|||
BC026-105 | GenDepot | 5g | EUR 684 |
Dopamine -13C8 Hydrochloride Salt |
|||
D533784 | Toronto Research Chemicals | 25mg | EUR 7600 |
Peramine Hydrochloride Salt-d3 |
|||
P285302 | Toronto Research Chemicals | 10mg | EUR 184 |
Carazolol-d6, Hydrochloride Salt |
|||
C175812 | Toronto Research Chemicals | 50mg | EUR 181 |
Description: 1184973-07-6 |
Tofenacin Hydrochloride Salt-d4 |
|||
T528502 | Toronto Research Chemicals | 10mg | EUR 190 |
17-DMAG, Hydrochloride Salt, >98% |
|||
BC024-001 | GenDepot | 1mg | EUR 213.6 |
17-DMAG, Hydrochloride Salt, >98% |
|||
BC024-005 | GenDepot | 5mg | EUR 343.2 |
17-DMAG, Hydrochloride Salt, >98% |
|||
BC024-010 | GenDepot | 10mg | EUR 489.6 |
17-DMAG, Hydrochloride Salt, >98% |
|||
BC024-025 | GenDepot | 25mg | Ask for price |
17-DMAG, Hydrochloride Salt, >99% |
|||
BC024-100 | GenDepot | 100mg | Ask for price |
17-DMAG, Hydrochloride Salt, >99% |
|||
BC024-101 | GenDepot | 1g | Ask for price |
17-DMAG, Hydrochloride Salt, >99% |
|||
BC024-250 | GenDepot | 250mg | Ask for price |
Flupirtine-d4 Hydrochloride Salt |
|||
F598512 | Toronto Research Chemicals | 10mg | EUR 215 |
Description: 1324717-75-0 |
Difloxacin-d3 Hydrochloride Salt |
|||
D445601 | Toronto Research Chemicals | 10mg | EUR 127 |
Description: 1173021-89-0 |
rac-Emixustat Hydrochloride Salt |
|||
B224873 | Toronto Research Chemicals | 1g | EUR 3000 |
Description: 1222169-23-4 |
Abeprazan dimer Hydrochloride salt |
|||
A642330 | Toronto Research Chemicals | 100mg | EUR 17000 |
Bromo Didehydro Doxorubicinone |
|||
B682880 | Toronto Research Chemicals | 25mg | EUR 1200 |
Description: 63626-06-2 |
cis-Mefentanyl Hydrochloride Salt |
|||
M205505 | Toronto Research Chemicals | 50mg | EUR 232 |
Description: 78995-18-3 |
rac Metanephrine Hydrochloride Salt |
|||
M258760 | Toronto Research Chemicals | 100mg | EUR 207 |
Description: 881-95-8 |
b-Isothipendyl Hydrochloride Salt |
|||
I902751 | Toronto Research Chemicals | 100mg | EUR 845 |
Description: 132962-42-6 |
Ondansetron-d3 Hydrochloride Salt |
|||
O655002 | Toronto Research Chemicals | 10mg | EUR 193 |
Description: 1346605-02-4 |
OSU-03012, Hydrochloride Salt, >98% |
|||
BC061-005 | GenDepot | 5mg | EUR 375.6 |
OSU-03012, Hydrochloride Salt, >98% |
|||
BC061-025 | GenDepot | 25mg | EUR 634.8 |
MEL3 Isomer I Hydrochloride Salt |
|||
M155671 | Toronto Research Chemicals | 50mg | EUR 15000 |
MEL3 Isomer II Hydrochloride Salt |
|||
M155672 | Toronto Research Chemicals | 50mg | EUR 7600 |
Dimethacrine Hydrochloride Salt-d3 |
|||
D460272 | Toronto Research Chemicals | 100mg | EUR 9200 |
Linear Daptomycin Hydrochloride Salt |
|||
L466475 | Toronto Research Chemicals | 2.5mg | EUR 269 |
Iso Desloratadine Hydrochloride Salt |
|||
I815005 | Toronto Research Chemicals | 10mg | EUR 1185 |
Volinanserin-d4 Hydrochloride Salt |
|||
V755002 | Toronto Research Chemicals | 10mg | EUR 265 |
Description: 1217617-73-6 |
2'-Nor Thiamine Hydrochloride Salt |
|||
N830500 | Toronto Research Chemicals | 100mg | EUR 249 |
Description: 49614-72-4 |
Tamsulosin Diether Hydrochloride Salt |
|||
E736620 | Toronto Research Chemicals | 100mg | EUR 695 |
Apovincaminic Acid Hydrochloride Salt |
|||
A729250 | Toronto Research Chemicals | 500mg | EUR 193 |
Description: 72296-47-0 |
Keto-Isoxsuprine Hydrochloride Salt |
|||
K606400 | Toronto Research Chemicals | 100mg | EUR 1200 |
Synephrine-13C2,15N Hydrochloride Salt |
|||
S920002 | Toronto Research Chemicals | 0.1mg | EUR 1722 |
Description: 1329499-30-0 |
Apovincaminic acid hydrochloride salt |
|||
T37406-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Apovincaminic acid hydrochloride salt |
Apovincaminic acid hydrochloride salt |
|||
T37406-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Apovincaminic acid hydrochloride salt |
Apovincaminic acid hydrochloride salt |
|||
T37406-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Apovincaminic acid hydrochloride salt |
Apovincaminic acid hydrochloride salt |
|||
T37406-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Apovincaminic acid hydrochloride salt |
Apovincaminic acid hydrochloride salt |
|||
T37406-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Apovincaminic acid hydrochloride salt |
Reticuline Hydrochloride Salt (>90% ee) |
|||
R188500 | Toronto Research Chemicals | 0.5mg | EUR 2070 |
Description: 903-91-3 |
(R)-Norphenylephrine Hydrochloride Salt |
|||
N825510 | Toronto Research Chemicals | 25mg | EUR 3000 |
Description: 636-87-3 |
Dehydroxy Mirabegron Hydrochloride Salt |
|||
D230170 | Toronto Research Chemicals | 250mg | EUR 201 |
Description: 1581284-79-8 |
5-Nitroisoindoline Hydrochloride Salt |
|||
N496370 | Toronto Research Chemicals | 1g | EUR 75 |
Description: 400727-69-7 |
Azetidin-3-ol Hydrochloride Salt |
|||
A813200 | Toronto Research Chemicals | 25g | EUR 357 |
Description: 18621-18-6 |